Thank you for Subscribing to Life Science Review Weekly Brief
Health Economics and Results Research (HEOR) has gained power and distinction among government and other stakeholders in health system decision-making. With precision medicine and value-based care playing an increasingly important role in the healthcare landscape, HEOR is also moving from a support function to a central role in pharmaceutical companies.
HEOR services can inform decision-making at many stages in the product life cycle, from R&D to pricing, market access, strategic planning to sales strategy and lifecycle management. These services play a significant role in drug approval and reimbursement with payers. The HEOR services also allow for evaluating the economics of treatment and quantifying the associated results.
Likewise, in the healthcare industry, decision-makers experience the pressure to opt for therapeutic ‘interventions’ from various treatment options made available by pharmaceuticals, medical devices, and biotechnology companies. Added to this is the constant pressure to control rising healthcare costs.
Indeed, HEOR services help decision-makers to adequately compare and understand the appropriate solution among all the available options. However, research conducted in the HEOR world is not an easy feet, especially with social distancing, isolation and restrained in-person interaction.
With in-person research becoming nearly impossible, innovation through technology has stepped in to ensure that the patient and payer voice would still be heard. Through the use of videoconference platforms, patient interviews and focus groups have become virtual, allowing global HEOR researchers to connect with patients in their own living rooms at their convenience. Similarly, virtual advisory boards and payer interviews have also helped eliminate the added expense and time associated with travel.
Today, healthcare policy priorities range from cost containment, more patient-centric policies, to universal access. Consequently, the current data is more quantitative in nature and should provide direction toward future qualitative surveys. The coming years will prove the importance of qualitative data and economic perspectives to determine the best reward mechanisms that maintain the incentives for development, yet ensure that society at large will reap the benefits.
Let us know your thoughts.
Hull Associates offers strategic market access and reimbursement consulting to support pharmaceutical, medical device, and diagnostics organizations.
Founded in 2003, Boston Strategic Partners (BSP) is a global advisory firm dedicated to the healthcare and life sciences industry. It offers five different services, including business and clinical strategy, health economics & outcomes research (HEOR), medical communications, regulatory strategy, and financial advisory.
Fabian D'Souza, President and FounderBSP has a strong clinical focus on demonstrating value. Our team comprises seven MDs, four PharmDs, over a dozen PhDs, and professionals with advanced qualifications across various aspects of healthcare
EVERSANA is the leading provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers.
EVERSANA
Management
Tim Disher, Senior Director, Biostatistics, Value & Evidence
Jim Lang, CEO
As an HEOR partner to healthcare systems, HRA delivers contextual insights by leveraging their decades of data management and statistical analysis expertise in using real-world data. The company’s unique value proposition is to provide actionable insights for improving health outcomes in a cost-effective manner.
Health Research and Analysis - HRA
Management
Samar DeBakey, MD, MPH, president.
Adelphi Values is a global healthcare value consultancy combining strategic thinking with a reputation for excellence in outcomes research, health economics, and market access. The company develops and deliver client-focused services through clinical development and commercialization with the goal of improving patients’ lives by informing healthcare decisions
Artia Solutions provide drug manufacturers with the resources, guidance, and support needed to successfully launch or manage their medical or pharmacy benefit products within the Medicaid and Medicaid Managed Care marketplaces. The company's vision is to ultimately enhance the lives of patients by creating access to essential medications
Informa champions specialists working in academic and business-to-business markets, connecting people with knowledge to help them learn more, know more and do more. The company is a leading international events, digital services and academic knowledge business, headquartered in the UK and a member of the UK’s FTSE 100 group of public companies
Nexus Patient Services is a full service pharmacy hub focused on finding solutions for pharmaceutical manufacturer clients to overcome access barriers and increase brand market share. The company’s services include hub services, reimbursement services, prior authorization support, direct to patient programs, direct to patient sampling, and co-pay savings cards
Point-of-Care Partners (POCP) is a leading management consulting firm assisting healthcare organizations in the evaluation, development, and implementation of winning health information management strategies in a rapidly evolving electronic world. The company’s accomplished healthcare consultants, core services, and methodologies are focused on positioning organizations for success in the integrated, data-driven world of value-based care
Developer of a digital mental health platform designed to keep care providers and patients connected. The company leverages deep technology for the early detection of depression and mood disorder symptoms while providing personalized assessments and feedback, enabling health care providers to monitor and support their patients in an optimized manner